UP!
| 2015-03-12 | Reiterated Rating | MLV & Co. | Buy | $11.00 |
| 2015-01-20 | Set Price Target | MLV & Co. | Buy | $11.00 |
| 2014-06-11 | Lower Price Target | MLV & Co. | Buy | $13.00 to $11.00 |
| 2014-04-16 | Initiated Coverage | Canaccord Genuity | Buy | $17.00 |
| 2013-12-05 | Initiated Coverage | MLV & Co. | Buy | |
| 2013-11-05 | Initiated Coverage | MLV & Co. | Buy | $13.00 |
| 2013-10-15 | Initiated Coverage | JMP Securities | Outperform | $14.00 |
| 1970-01-01 |
| 2015-03-12 | Reiterated Rating | MLV & Co. | Buy | $11.00 |
| 2015-01-20 | Set Price Target | MLV & Co. | Buy | $11.00 |
| 2014-06-11 | Lower Price Target | MLV & Co. | Buy | $13.00 to $11.00 |
| 2014-04-16 | Initiated Coverage | Canaccord Genuity | Buy | $17.00 |
| 2013-12-05 | Initiated Coverage | MLV & Co. | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In LPTN 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| LEHMAN BROTHERS HOLDINGS INC. PLAN TRUST | 77.51% (12105311) | AVB / LPTN / |
| BARCLAYS PLC | 33.98% (5307300) | HITT / ICON / LPTN / WAC / |
| Swortwood Letitia | 33.58% (5244115) | LPTN / |
| STONEPINE CAPITAL, L.P. | 16.51% (2577996) | LPTN / |
| Roaring Fork Capital SBIC, L.P. | 16.42% (2563816) | LPTN / |
| Robertson Bruce C | 9.29% (1451185) | LPTN / NWBO / |
| H.I.G. Ventures - Endosurgery, LLC | 9.29% (1451185) | LPTN / |
| Remeditex Ventures LLC | 8.38% (1309392) | LPTN / MNLO / |
| Creecy John W | 8.38% (1309392) | LPTN / SGNL / |
| Novo A/S | 8.34% (1301842) | AKBA / ALDR / CRVS / FLXN / INGN / LPTN / OPHT / OTIC / RETA / RGDO / ZSPH / |
| Sabbadini Roger Allen VP & Chief Scientific Officer | 6.63% (1035800) | LPTN / |
| McGaughy R Kent Jr | 3.00% (469100) | LPTN / RETA / |
| Newton Todd Chief Executive Officer | 1.07% (167129) | ARTC / LPTN / |
| PANCOAST SCOTT R President & CEO | 0.75% (116435) | LPTN / |
| KISNER DANIEL L | 0.45% (70590) | CNAT / DVAX / LPTN / TKMR / |
| McWilliams Dennis L. President, CCO | 0.40% (62404) | LPTN / |
| Crawford Matthew S | 0.34% (53715) | LPTN / |
| Garland William A VP - Drug Development | 0.32% (50000) | LPTN / |
| Anderson Rick D | 0.32% (49677) | LPTN / |
| MEELIA RICHARD J | 0.29% (45454) | HAE / LPTN / |
| Atkinson Gary J G VP, CFO and Secretary | 0.23% (35441) | LPTN / |
| Schwartzhoff Bret V.P. U.S. Sales and Marketing | 0.19% (28958) | LPTN / |
| Hansen Genevieve Vice President of R&D | 0.13% (21000) | LPTN / |
| MATHEWS CHARLES | 0.13% (19916) | AVNR / LPTN / |
| Ferrell Jeffrey | 0.08% (12486) | LPTN / |
| Petree Daniel H | 0.07% (11155) | LPTN / |
| Swortwood Donald | 0.06% (9200) | LPTN / |
| Cavanaugh Stefanie L. CFO, Treasurer, Secretary | 0.06% (9166) | LPTN / |
| Pacitti David | 0.02% (3337) | LPTN / |
| McClellan William D. Jr. | 0.01% (2000) | LPTN / RETA / |
UM